Yingying Cong

University Medical Center Groningen — Netherlands

Medicine · Health Sciences

18h-index1.4kcitations43works1.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

SARS-CoV-2 and COVID-19 Research(10), Animal Virus Infections Studies(10), Viral gastroenteritis research and epidemiology(8), Virus-based gene therapy research(4), Bone health and treatments(4)

Publications43 total

Resolving Incompatible Blood Cross-Matching: The Role of 37°C Water Bath in Transfusion Safety
Journal of Blood Medicine·2025Open Access
Hijacking a cellular highway: non-lipidated LC3 proteins and PCNT (pericentrin) drive influenza a virus uncoating
Autophagy·2025Open Access
STING signals to NF-κB from late endolysosomal compartments using IRF3 as an adaptor
Nature Immunology·2025· 6 cited
Best Evidence Summary for the Management of Pediatric Burn Wounds
Psycho-Oncologie·2025Open Access
Risk prediction models for heart failure after myocardial infarction: A systematic review
Medicine·2025Open Access
Influenza A virus subverts the LC3-pericentrin dynein adaptor complex for host cytoplasm entry
Science Advances·2025· 6 citedOpen Access
[Current researches and influencing factors of health-related quality of life in patients with pulmonary hypertension].
PubMed·2025
Small‐Molecule Allosteric Inhibitors of Human Aspartate Transcarbamoylase Suppress Proliferation of Bone Osteosarcoma Epithelial Cells
ChemMedChem·2024· 1 citedOpen Access
Getting on the right track: Interactions between viruses and the cytoskeletal motor proteins
Traffic·2022· 16 citedOpen Access
Hypericin Inhibit Alpha-Coronavirus Replication by Targeting 3CL Protease
Viruses·2021· 39 citedOpen Access
<i>WDR45</i>, one gene associated with multiple neurodevelopmental disorders
Autophagy·2021· 59 citedOpen Access
<i>WDR45</i>, one gene associated with multiple neurodevelopmental disorders
University of Groningen research database (University of Groningen / Centre for Information Technology)·2021Open Access
Repurposing the HCV NS3–4A protease drug boceprevir as COVID-19 therapeutics
RSC Medicinal Chemistry·2020· 82 citedOpen Access
Repurposing the HCV NS3–4A protease drug boceprevir as COVID-19 therapeutics†‡ † Available crystal structures of boceprevir–3CLpro and telaprevir–3CLpro complexes are available at PDB under codes 6ZRU and 6ZRT respectively.‡ Electronic supplementary information (ESI) available. See DOI: 10.1039/d0md00367k
2020
SARS-Cov2 S protein at open state
2020
SARS-Cov2 S protein at close state
2020
A glance on anti-viral strategy target Coronavirus life cycle
Journal of Applied Virology·2020Open Access
Manipulation of selective macroautophagy by pathogens at a glance
Journal of Cell Science·2020· 21 citedOpen Access
Nucleocapsid Protein Recruitment to Replication-Transcription Complexes Plays a Crucial Role in Coronaviral Life Cycle
Journal of Virology·2019· 406 citedOpen Access
Molecular insights into viral respiratory infections
Data Archiving and Networked Services (DANS)·2019· 4 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Fulvio Reggiori(14), Xiaofeng Ren(7), Mario Mauthe(4), Siqingaowa Suo(4), Li Cai(4), Rick Oerlemans(3), Angel J. Ruiz‐Moreno(3), Matthew R. Groves(3), Alexander Dömlingꝉ(3), Amanda Forsyth(3), Carrie S. Shemanko(3), Pauline Verlhac(3), Franziska Kriegenburg(2), Cornelis A. M. de Haan(2), Xiaonan Lv(2), Nilima Dinesh Kumar(2), Marco A. Velasco‐Velázquez(2), Constantinos G. Neochoritis(2), Vincent So(2), Marina A.J. Tijssen(2)